Biotech

All Articles

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and a preclinical immune...

Ventyx's last resort for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's condition medicine performed not assist patients attain remission in a ...

Cognition's period 2 SHINE information blemish Alzheimer's possibility

.Knowledge Rehabs' period 2 sparkle trial has actually taken some of the gloss off the Alzheimer's d...

BMS centers bispecific months after submitting to work stage 3 test

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who oversaw Mirati Therapies' $ 5.8 billion purchase to Bristol Myers Sq...

Asarina to close after efforts to partner Tourette's medicine fall short

.After connecting to greater than 200 companies to partner a Tourette syndrome therapy that presente...

Novartis pens $150M beforehand bispecifics cope with Dren Biography

.Novartis has possessed some bad luck along with bispecific antitoxins in the past, however judging ...

AstraZeneca plants an EGFR tree with Pinetree offer worth $45M

.Pinetree Therapeutics are going to assist AstraZeneca vegetation some plants in its pipe with a new...

GRO collects $60M collection B to take gout arthritis therapy into medical clinic

.GRO Biosciences has actually finished the full week along with an additional $60.3 million in the b...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses chief executive officer

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings and al...